Login / Signup
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors.
Mayur Garg
Simon G Royce
John S Lubel
Published in:
Alimentary pharmacology & therapeutics (2020)
Keyphrases
</>
coronavirus disease
sars cov
oxidative stress
angiotensin converting enzyme
angiotensin ii
wild type
respiratory syndrome coronavirus